Transportation Analyst
About the job
- Advanced data analytics, statistical analysis, cost modeling, and financial evaluation of transportation and logistics operations.
- Expertise in Microsoft Excel, Power BI or Tableau, business intelligence reporting, dashboard development, and data visualization.
- Knowledge of transportation management, freight cost analysis, carrier performance measurement, logistics network optimization, and supply chain processes.
- Experience with transportation management systems, SAP or enterprise resource planning reporting systems, freight market intelligence platforms such as Xeneta, DAT, and FreightWaves, and logistics data management.
- Proficiency in SQL and/or Python for data extraction, modeling, automation, and advanced analytics.
- Bachelor’s degree in supply chain, industrial engineering, data science, or analytics.
- Two to five years of supply chain or logistics analytics experience.
- Strong quantitative and data visualization skills.
- Transportation management system and enterprise resource planning reporting experience.
- Build and maintain freight cost dashboards across ocean, air, full truckload, less-than-truckload, parcel, and drayage modes.
- Benchmark freight rates against market indices, including DAT, Xeneta, and Freightos, monthly.
- Perform invoice-to-contract audit analytics and identify systematic overcharges.
- Model the cost impact of network changes, such as NDC consolidation and mode shifts.
- Support RACI by flagging spend outside contracted thresholds in near real time.
- Continuously model distribution center network configuration and analyze Memphis, Manassas, and New Jersey splits versus NDC flows.
- Identify less-than-truckload to full-truckload consolidation opportunities by lane and frequency.
- Analyze parcel versus less-than-truckload threshold optimization by customer and zone.
- Model air-to-ocean shift opportunities on inbound freight.
- Evaluate distribution center bypass opportunities, including direct flows from NDC to wholesalers.
- Own the monthly logistics performance scorecard.
- Build carrier performance analytics for quarterly business reviews.
- Provide freight forecasting models aligned with the commercial forecast.
- Report on demurrage and detention trends and cost drivers.
- Support the sales and operations planning process with transportation capacity and cost inputs.
- Track freight cost per pallet across all modes, cost per ocean and air container, network cost versus benchmark, identified versus realized optimization savings, and freight forecast accuracy.
- Lead change through innovative thinking and active use of packaging improvement tools and techniques.
- Work with internal stakeholders and service providers as required by the business.
- Pharmaceutical industry experience.
About the company
Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
2014
Get referred to Granules
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
- July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
- Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.
What critics are saying
- FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
- Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
- Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.
What makes Granules unique
- Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
- February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
- Granules shipped in 80 countries and won 94 approvals by August 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Flexible Work Hours